Sunil Agarwal's Net Worth
$15.2 Million
Who is Sunil Agarwal?
Sunil Agarwal has an estimated net worth of $15.2 Million. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., Ultragenyx Pharmaceutical Inc., MyoKardia, Inc., Calithera Biosciences, Inc., Juno Therapeutics, Inc., and ARVINAS, INC..
SEC CIK
Sunil Agarwal's CIK is 0001616640
Past Insider Trading and Trends
2020 was Sunil Agarwal's most active year for acquiring shares with 6 total transactions. Sunil Agarwal's most active month to acquire stocks was the month of May. 2015 was Sunil Agarwal's most active year for disposing of shares, totalling 17 transactions. Sunil Agarwal's most active month to dispose stocks was the month of July. 2015 saw Sunil Agarwal paying a total of $558,800.00 for 62,700 shares, this is the most they've acquired in one year. In 2021 Sunil Agarwal cashed out on 60,000 shares for a total of $1,564,056.92, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Sana Biotechnology, Inc. (SANA) Snapshot price: $6.145
EVP, Head Development & CMO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
| -3.73% | -60.00K |
$26.07 | -$1,564,056.92 | 1.55M |
Scheduled
|
Sep 15 - Sep 16
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ultragenyx Pharmaceutical Inc. (RARE) Snapshot price: $44.915
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.11% | -392.00 |
$66.00 | -$25,872.00 | 9.14K |
Aug 19
| |||
Form 4
| -9.85% | -1.04K |
$51.88 | -$54,004.92 | 9.53K |
Scheduled
|
Jul 19 - Jul 21
| ||
Form 4
| -8.97% | -1.04K |
$54.47 | -$56,760.08 | 10.57K |
Scheduled
|
Jun 19 - Jun 20
| ||
Form 4
| +63.28% | 4.5K |
—
|
—
| 11.61K |
Jun 1
| |||
Form 4
| -8.38% | -650.00 |
$66.00 | -$42,900.00 | 7.11K |
Scheduled
|
May 24
| ||
Form 4
| -9.41% | -806.00 |
$62.77 | -$50,592.46 | 7.76K |
May 19 - May 21
| |||
Form 4
| -10.83% | -1.04K |
$70.28 | -$73,159.09 | 8.57K |
Scheduled
|
Apr 19 - Apr 20
| ||
Form 4
| -6.34% | -650.00 |
$61.45 | -$39,942.50 | 9.61K |
Scheduled
|
Mar 22
| ||
Form 4
| -3.68% | -392.00 |
$56.32 | -$22,077.44 | 10.26K |
Mar 19
| |||
Form 4
| -8.91% | -1.04K |
$63.40 | -$66,065.52 | 10.65K |
Scheduled
|
Feb 19 - Feb 22
| ||
Form 4
| -7.87% | -1.04K |
$72.26 | -$75,218.67 | 12.19K |
Scheduled
|
Jan 19 - Jan 20
| ||
Form 4
| -3.63% | -498.00 |
$114.81 | -$57,175.38 | 13.23K |
Scheduled
|
Dec 22
| ||
Form 4
| -3.81% | -544.00 |
$109.87 | -$59,769.28 | 13.73K |
Dec 19
| |||
Form 4
| -3.49% | -498.00 |
$95.88 | -$47,748.24 | 13.78K |
Scheduled
|
Nov 23
| ||
Form 4
| -3.67% | -544.00 |
$97.71 | -$53,154.24 | 14.27K |
Nov 19
| |||
Form 4
| -6.56% | -1.04K |
$86.80 | -$90,360.47 | 14.82K |
Scheduled
|
Oct 19 - Oct 20
| ||
Form 4
| -3.04% | -498.00 |
$109.51 | -$54,535.98 | 15.86K |
Scheduled
|
Sep 22
| ||
Form 4
| -3.22% | -544.00 |
$129.91 | -$70,671.04 | 16.36K |
Sep 19
| |||
Form 4
| -42.52% | -12.50K |
$84.24 | -$1,974,517.08 | 16.9K |
Scheduled
|
Aug 19 - Aug 20
| ||
Form 4
| +17.60% | 4.4K |
—
|
—
| 29.4K |
May 21
| |||
Form 4
|
∞
| 25K |
—
|
—
| 25K |
Aug 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MyoKardia, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.10K |
—
|
—
|
0
|
Nov 17
| |||
Form 4/A
|
∞
| 2.3K |
—
|
—
| 2.3K |
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
∞
| 2.3K |
—
|
—
| 2.3K |
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Calithera Biosciences, Inc. (CALA) Snapshot price: $0.03
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Juno Therapeutics, Inc. No price found
President R & D
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -149.58K |
—
|
—
|
0
|
Mar 5
| |||
Form 4
| +24.19% | 29.14K |
—
|
—
| 149.58K |
Jan 31
| |||
Form 4
| +42.45% | 35.89K |
—
|
—
| 120.44K |
Oct 20
| |||
Form 4
| -7.93% | -7.29K |
$44.76 | -$326,088.26 | 84.55K |
Scheduled
|
Oct 2
| ||
Form 4
|
∞
| 91.83K |
$24.01 | -$115,079.93 | 91.83K |
Apr 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||